跳到正文
原文
Medical Xpress·· 17 天前精选AI 评分63

坏邻居:免疫细胞如何帮助癌细胞准备转移

Bad neighbors: How immune cells help cancer cells get ready to spread

AI 导读

研究人员发现,免疫细胞在癌细胞转移过程中扮演关键角色,通过不同类型的白细胞释放分子信号,促进癌细胞进入转移状态。这一发现为开发新的抗转移疗法提供了新视角。

推荐理由

揭示了免疫细胞在癌细胞转移过程中的作用机制,为开发新的抗转移疗法提供了新视角。

正文
Bad neighbors: How immune cells help cancer cells get ready to spread
Immunohistochemistry showing pSTAT3, pSMAD2 and MPO staining in mouse skin SCC tumor sections with different EMT states. Credit: Nature Cancer (2026). DOI: 10.1038/s43018-026-01259-3

Most cancer deaths are not caused by the original tumor, but by metastases, which form when cancer cells leave the original tumor and spread to other organs. To do so, cancer cells must loosen their attachment to other cancer cells and become more mobile so they can move away from the tumor, a process called epithelial-to-mesenchymal transition, or EMT. EMT is a progressive phenomenon, and cancer cells go through an intermediate "hybrid" stage that is the best at forming metastases.

Researchers at the Université libre de Bruxelles (ULB) have discovered that immune cells build distinct "neighborhoods" around cancer cells. In one of these neighborhoods, immune cells communicate with cancer cells to promote their ability to spread to distant organs and mediate metastasis formation.

The research, which could eventually help develop new therapies to target metastasis, is published in the journal Nature Cancer. It was led by Cédric Blanpain, M.D., Ph.D., an investigator at the WEL Research Institute, director of the Laboratory of Stem Cells and Cancer and professor at the Université libre de Bruxelles.

Tumors contain cancer cells as well as normal cells and blood vessels, which usually help cancer cells grow. The researchers wanted to know which normal neighboring cells surround cancer cells during EMT and how these normal cells communicate with cancer cells to give rise to metastasis.

Each stage has its own neighborhood

Like a city divided into districts, each with its own residents, the tumor is organized into distinct neighborhoods. Hybrid EMT cancer cells are surrounded by a subset of white blood cells called neutrophils, whereas in the most advanced stage of EMT, cancer cells are surrounded by another type of white blood cell called macrophages.

To assess the role of these different white blood cells in regulating EMT and metastasis, the researchers experimentally removed these immune cells. When the researchers removed neutrophils in mice, the number of hybrid EMT cancer cells decreased, which led to fewer lung metastases. In contrast, removing macrophages led to an increase in hybrid EMT cancer cells but had no effect on lung metastases.

"It was striking to see that neutrophils and macrophages occupy different territories around cancer cells. When we removed neutrophils in mice, the hybrid cancer cells were strongly reduced, but more importantly, this led to a strong decrease in metastasis, suggesting that the dialogue between neutrophils and cancer cells controls their metastatic potential," explains Dr. Anqi Dong, co-first author of the study.

Two messages, two neighborhoods

The researchers then looked for the molecules that these two types of white blood cells use to "talk" to cancer cells. They found that neutrophils release a molecule called oncostatin M, which pushes cancer cells into the hybrid state of EMT. When the researchers gave mice a drug that blocks oncostatin M, the number of hybrid cancer cells went down. Macrophages, in contrast, release another molecule, TGFβ1, which starts EMT and drives cancer cells toward its most advanced stage.

"By dissecting for the first time the molecular dialogue between the immune cells and the tumor cells during EMT, we uncovered oncostatin M and TGFβ1 as two of the key molecules that regulate EMT and metastatic dissemination," explains Dr. Sebastiaan Vanuytven, co-first author of the study.

Presence in human cancers

To find out whether their findings also apply to human cancers, the researchers looked for similar neighborhoods and the same molecular dialogue around hybrid cancer cells in human tumors. They found neutrophils producing oncostatin M next to hybrid cancer cells in human breast, pancreatic, lung and bladder cancers. This suggests that the same mechanism is present in at least some human cancers.

Why it matters

Hybrid EMT cancer cells are the most likely to spread and to resist anticancer therapy. Knowing which signals keep cancer cells in this dangerous state opens new avenues to prevent metastasis and sensitize tumor cells to therapy.

"Our study shows that EMT in cancer cells and the ability to give rise to metastasis are not only decided by the cancer cells, but are also influenced by the molecular dialogue between white blood cells and the cancer cells. It will be important to assess whether targeting the signals we have identified in this study, such as oncostatin M, could help to prevent metastasis and improve response to anticancer therapy," says Blanpain, who led the study.

Publication details

Anqi Dong et al., Myeloid-derived TGFβ1 and oncostatin M establish two distinct stromal niches controlling late and hybrid EMT states, Nature Cancer (2026). DOI: 10.1038/s43018-026-01259-3

Journal information: Nature Cancer

Clinical categories

Oncology

Who's behind this story?

Lisa Lock

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Bad neighbors: How immune cells help cancer cells get ready to spread (2026, November 3) retrieved 3 November 2026 from https://medicalxpress.com/news/2026-11-bad-neighbors-immune-cells-cancer.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com